Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease (Q36208008)

12 August 2017

1 reference

title

Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease (English)

1 reference

12 August 2017

1 reference

T Matsubara

1

1 reference

12 August 2017

T Ichiyama

series ordinal

2

1 reference

12 August 2017

S Furukawa

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

1 September 2005

1 reference

Clinical and Experimental Immunology

12 August 2017

1 reference

12 August 2017

141

1 reference

12 August 2017

3

1 reference

12 August 2017

381-387

1 reference

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Advances in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

MHC class II-dependent peptide antigen versus superantigen presentation to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Spontaneous tumor necrosis factor production in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02821.X

Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease

21 January 2018

1 reference

12 December 2020

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

1 reference

12 December 2020

Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo

1 reference

12 December 2020

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease

1 reference

12 December 2020

Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease

1 reference

12 December 2020

Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease

1 reference

12 December 2020

Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease

1 reference

12 December 2020

T cell Vbeta repertoires in childhood vasculitides

1 reference

12 December 2020

Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease

1 reference

12 December 2020

1 reference

12 December 2020

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

1 reference

12 December 2020

Immunoregulatory abnormalities in mucocutaneous lymph node syndrome

1 reference

12 December 2020

Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome

1 reference

12 December 2020

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

12 December 2020

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

12 December 2020

Pathology of the heart in Kawasaki disease

1 reference

12 December 2020

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

1 reference

12 December 2020

Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease

1 reference

12 December 2020

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

12 December 2020

CD14+CD16+ monocyte subpopulation in Kawasaki disease

1 reference

12 December 2020

Abnormalities of immunoregulation in Kawasaki syndrome

1 reference

12 December 2020

Circulating interleukin-1 beta in patients with Kawasaki disease

1 reference

12 December 2020

Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease

1 reference

12 December 2020

Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.

1 reference

12 December 2020

TCR V beta family repertoire and T cell activation markers in Kawasaki disease.

1 reference

12 December 2020

Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation

1 reference

12 December 2020

Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation

1 reference

12 December 2020

Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation

1 reference

12 December 2020

High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease

1 reference

12 December 2020

Clonal expansion of CD8+ T cells in Kawasaki disease

1 reference

12 December 2020

No increase in soluble Fas and Fas ligand in Kawasaki disease: comment on the article by Nozawa et al

1 reference

12 December 2020

IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.

1 reference

12 December 2020

Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation

1 reference

12 December 2020

Characterization of the T-Cell Receptor V-beta Repertoire in Kawasaki Disease

1 reference

12 December 2020

Twenty-five types of T-cell receptor Vbeta family repertoire in patients with Kawasaki syndrome

1 reference

12 December 2020

CTLA-4-Mediated inhibition of early events of T cell proliferation.

1 reference

12 December 2020

Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease

1 reference

12 December 2020

Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease

1 reference

12 December 2020

CD28/CTLA-4 and CD80/CD86 families: signaling and function

1 reference

12 December 2020

Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment

1 reference

12 December 2020

Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease

1 reference

12 December 2020

Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions

1 reference

12 December 2020

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease

1 reference

12 December 2020

Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease

1 reference

12 December 2020

Mononuclear cell subsets and coronary artery lesions in Kawasaki disease

1 reference

12 December 2020

Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron microscopic study

1 reference

12 December 2020

NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease

1 reference

12 December 2020

Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions

1 reference

12 December 2020

Comparison of Kawasaki Disease and Infectious Mononucleosis in Terms of Natural Killer Cell and CD8+T Cell Subsets

1 reference

12 December 2020

Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

Serum soluble CD4 and CD8 levels in Kawasaki disease

1 reference

12 December 2020

Increased Expression of FcεR2/CD23 on Peripheral Blood B Lymphocytes and Serum IgE Levels in Kawasaki Disease

1 reference

12 December 2020

Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum

1 reference

12 December 2020

Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease

1 reference

12 December 2020

10.1111/J.1365-2249.2005.02821.X

Identifiers

DOI

1 reference

12 August 2017

1 reference